Open enrollment
A 43-amino acid synthetic peptide modeled after thymosin beta-4.- Reported to regulate actin dynamics via its LKKTETQ sequence, thereby influencing cellular migration and motility.- May also elevate microRNA-146a, which suppresses inflammatory pathways involving IRAK1 and TRAF6.- Preclinical studies point toward roles in wound contraction, tissue vascularization, and cardiac resilience under stress
Potential Benefits: Enhanced Muscle Growth: Direct stimulation of GH production helps increase muscle mass and improves muscle strength by enhancing protein synthesis and promoting new muscle cell growth
Fineman M, Weyer C, Maggs DG, Strobel S, Kolterman OG
Because AOD9604 is not FDAapproved and cannot be compounded under current guidance, it is offered only under a strict informed consent framework with full transparency about its investigational status, potential risks, and mixed efficacy data